A retrospective chart review to assess the safety of nonablative fractional laser resurfacing in fitzpatrick skin types IV to VI

Charlotte M. Clark, Jonathan I. Silverberg, Andrew F. Alexis*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Background: Laser resurfacing in patients with Fitzpatrick skin phototypes (SPT) IV to VI is associated with a higher risk of pigmentary alteration. There is a paucity of studies evaluating optimum treatment parameters for fractional lasers in darkly pigmented skin types. Methods: This is a retrospective review of medical records for patients with SPT IV to VI who were treated with a 1,550 nm erbiumdoped fractional nonablative laser (Fraxel Re: Store SR 1550; Solta Medical, Hayword, CA). Data were collected from patient charts and the clinic laser logbook from January 2008 to January 2012. The frequency of treatment-associated postinflammatory hyperpigmentation (PIH) and treatment settings used were evaluated.

Original languageEnglish (US)
Pages (from-to)428-431
Number of pages4
JournalJournal of Drugs in Dermatology
Volume12
Issue number4
StatePublished - Apr 1 2013

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'A retrospective chart review to assess the safety of nonablative fractional laser resurfacing in fitzpatrick skin types IV to VI'. Together they form a unique fingerprint.

Cite this